Explore more publications!
Alabama STEM News
Submit Press Release

Alabama STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alabama STEM News.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 16, 2025

Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
September 16, 2025

Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732

Indeterminate GlobeNewswire
Telnyx Expands to Sydney with New Office Location, Bringing Real-Time AI Voice Infrastructure to APAC
September 16, 2025

Telnyx Expands to Sydney with New Office Location, Bringing Real-Time AI Voice Infrastructure to APAC

Indeterminate GlobeNewswire
Geotab’s New AI Dash Cam Slashes Risky Driving Behaviors by Up to 95% with In Cab Verbal Alerts
September 16, 2025

Geotab’s New AI Dash Cam Slashes Risky Driving Behaviors by Up to 95% with In Cab Verbal Alerts

Indeterminate GlobeNewswire
Intermap Technologies Files Final Short-Form Base Shelf Prospectus
September 16, 2025

Intermap Technologies Files Final Short-Form Base Shelf Prospectus

Indeterminate GlobeNewswire
NVIDIA and United Kingdom Build Nation’s AI Infrastructure and Ecosystem to Fuel Innovation, Economic Growth and Jobs
September 16, 2025

NVIDIA and United Kingdom Build Nation’s AI Infrastructure and Ecosystem to Fuel Innovation, Economic Growth and Jobs

Indeterminate GlobeNewswire
Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
September 16, 2025

Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak

Indeterminate GlobeNewswire
Theratechnologies reçoit l’approbation définitive du tribunal relativement au plan d’arrangement proposé visant son acquisition par Future Pak
September 16, 2025

Theratechnologies reçoit l’approbation définitive du tribunal relativement au plan d’arrangement proposé visant son acquisition par Future Pak

Indeterminate GlobeNewswire
Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser
September 16, 2025

Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser

Indeterminate GlobeNewswire
Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting
September 16, 2025

Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting

Indeterminate GlobeNewswire
NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana
September 16, 2025

NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana

Indeterminate GlobeNewswire
Snail Games 将与 Frozen Way Games 携《蜂巢：异星物语》亮相 2025 东京电玩展，加强全球市场布局
September 16, 2025

Snail Games 将与 Frozen Way Games 携《蜂巢：异星物语》亮相 2025 东京电玩展，加强全球市场布局

Indeterminate GlobeNewswire
Snail Games 與 Frozen Way Games 聯袂出席 2025 年東京電玩展，以《Honeycomb: The World Beyond》鞏固全球市場地位
September 16, 2025

Snail Games 與 Frozen Way Games 聯袂出席 2025 年東京電玩展，以《Honeycomb: The World Beyond》鞏固全球市場地位

Indeterminate GlobeNewswire
Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types
September 16, 2025

Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types

Indeterminate GlobeNewswire
Award-Winning AI Search Monitoring Platform Otterly.AI Launches Generative Engine Optimization (GEO) Audit Tool to Maximize AI Chatbot Visibility
September 16, 2025

Award-Winning AI Search Monitoring Platform Otterly.AI Launches Generative Engine Optimization (GEO) Audit Tool to Maximize AI Chatbot Visibility

Indeterminate GlobeNewswire
New Bear Alley–MTA360 Alliance Expands Lead Generation Power for Home-Service and Local Businesses
September 16, 2025

New Bear Alley–MTA360 Alliance Expands Lead Generation Power for Home-Service and Local Businesses

Indeterminate GlobeNewswire
IDT Corporation to Present at Sidoti September Investor Conference
September 16, 2025

IDT Corporation to Present at Sidoti September Investor Conference

Indeterminate GlobeNewswire
Exion Edge 2025: How Exion Edge AI Platform Is Transforming Automated Trading Systems – Read Germany Report!
September 16, 2025

Exion Edge 2025: How Exion Edge AI Platform Is Transforming Automated Trading Systems – Read Germany Report!

Indeterminate GlobeNewswire
NewsGenie Launches CivilyzeIt™ to Tackle Hate Speech Without Sacrificing Free Speech
September 16, 2025

NewsGenie Launches CivilyzeIt™ to Tackle Hate Speech Without Sacrificing Free Speech

Indeterminate GlobeNewswire
CZM × MetaFusion: Super Alliance of Medical Technology and Globally Compliant Finance Launches
September 16, 2025

CZM × MetaFusion: Super Alliance of Medical Technology and Globally Compliant Finance Launches

Indeterminate GlobeNewswire
IGEL Redefines Ransomware Recovery: Instant Business Continuity, No Device Shipping
September 16, 2025

IGEL Redefines Ransomware Recovery: Instant Business Continuity, No Device Shipping

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions